Cancer/testis antigens and gametogenesis: a review and "brain-storming" session.
Genes expressed both in normal testis and in malignancies (Cancer/ Testis associated genes - CTA) have become the most extensively studied antigen group in the field of tumour immunology. Despite this, many fundamentally important questions remain unanswered: what is the connection between germ-cell specific genes and tumours? Is the expression of these genes yet another proof for the importance of genome destabilisation in the process of tumorigenesis?, or maybe activation of these genes is not quite random but instead related to some programme giving tumours a survival advantage?This review collates most of the recent information available about CTAs expression, function, and regulation. The data suggests a programme related to ontogenesis, mostly to gametogenesis. In the "brain-storming" part, facts in conflict with the hypothesis of random CTA gene activation are discussed. We propose a programme borrowed from organisms phylogenetically much older than humans, which existed before the differentiation of sexes. It is a programme that has served as a life cycle with prominent ploidy changes, and from which, as we know, the germ-cell ploidy cycle - meiosis - has evolved. Further work may show whether this hypothesis can lead to a novel anti-tumour strategy.
Kalejs
Martins
M
Biomedical Research and Study Centre of the Latvian University, Riga, Latvia. m.kalejs@no.lv.
Erenpreisa
Jekaterina
J
Nature. 2001 May 17;411(6835):349-54
11357142
Immunogenetics. 1992;35(3):145-52
1537606
Biochem Biophys Res Commun. 1996 Jul 16;224(2):318-26
8702389
Int Rev Cytol. 1996;165:53-119
8900957
Nat Rev Cancer. 2002 Jul;2(7):514-20
12094237
Gene. 2003 Dec 24;323:189-99
14659893
Chromosoma. 2003 Oct;112(3):124-32
14579128
Nucleic Acids Res. 1994 Dec 25;22(25):5640-8
7838717
Mol Med Today. 1997 Aug;3(8):342-9
9269687
Cell Biol Int. 2000;24(9):621-33
10964452
Cell Biol Int. 2000;24(9):635-48
10964453
EMBO J. 1992 Dec;11(13):5091-100
1464329
Genes Chromosomes Cancer. 2003 Jun;37(2):195-200
12696068
Curr Opin Immunol. 1997 Oct;9(5):709-16
9368781
Genomics. 1997 Dec 15;46(3):450-8
9441749
Cell Prolif. 1996 Feb;29(2):89-100
8630339
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6025-30
8650213
Fertil Steril. 1997 Feb;67(2):355-61
9022615
J Cell Physiol. 2003 Mar;194(3):272-88
12548548
J Biol Chem. 1996 Nov 15;271(46):29265-70
8910586
Transplantation. 1963 Apr;1:174-80
14010646
Oncogene. 2002 May 30;21(24):3879-88
12032826
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3282-7
11248070
Nature. 2003 May 22;423(6938):448-52
12717451
Int J Cancer. 1998 Oct 29;78(3):387-9
9766577
Immunogenetics. 1994;40(5):360-9
7927540
Mol Genet Metab. 1998 Jan;63(1):3-13
9538511
Cancer Immun. 2001 Mar 30;1:1
12747762
Clin Cancer Res. 2000 Jul;6(7):2712-7
10914715
J Leukoc Biol. 1996 Sep;60(3):296-309
8830785
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1914-8
9050879
Jpn J Cancer Res. 1996 Jul;87(7):751-6
8698626
Am J Reprod Immunol. 1998 Sep;40(3):172-6
9764361
Biochem Biophys Res Commun. 2002 Apr 5;292(3):715-26
11922625
Int J Cancer. 2002 Jun 20;99(6):839-45
12115486
Int J Cancer. 1998 Jul 17;77(2):200-4
9650552
Histochem Cell Biol. 2002 Mar;117(3):243-55
11914922
Mol Cell Biol. 2003 Aug;23(15):5354-65
12861021
Lancet Oncol. 2002 Jun;3(6):357-63
12107023
Cancer Res. 2000 Jul 15;60(14):3848-55
10919659
J Cell Sci. 2003 Oct 15;116(Pt 20):4095-106
12953071
Int J Cancer. 2001 Jun 15;92(6):856-60
11351307
Cancer Res. 2002 Nov 15;62(22):6750-5
12438276
Int J Cancer. 2002 May 20;99(3):361-9
11992404
Nature. 2003 May 22;423(6938):409-14
12717450
Hum Mol Genet. 1997 Sep;6(9):1549-58
9285793
Mol Reprod Dev. 2001 Jan;58(1):116-25
11144214
J Biol Chem. 2001 Dec 28;276(52):49378-89
11590179
Science. 1991 Dec 13;254(5038):1643-7
1840703
Int J Cancer. 2000 Feb 15;85(4):460-5
10699915
Lab Invest. 2002 Jun;82(6):775-80
12065688
Semin Cancer Biol. 2002 Oct;12(5):399-414
12191639
J Urol. 2001 May;165(5):1790-4
11342977
Life Sci. 1998;62(25):2275-82
9651116
Genomics. 1999 Oct 15;61(2):156-69
10534401
Cancer Res. 2002 Jan 1;62(1):290-4
11782390
Cancer Res. 2002 Jan 1;62(1):219-25
11782381
Clin Cancer Res. 2000 May;6(5):1833-9
10815905
Am J Clin Pathol. 2001 Sep;116(3):360-8
11554164
Pathology. 2004 Apr;36(2):120-8
15203747
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6806-11
12011441
Oncogene. 2002 Jun 13;21(26):4181-90
12037676
Science. 1992 Aug 14;257(5072):967-71
1354393
Biol Reprod. 2000 Aug;63(2):469-81
10906052
Proc Natl Acad Sci U S A. 1975 Sep;72(9):3585-9
1059147
Int J Cancer. 2002 Apr 1;98(4):485-92
11920606
Genes Dev. 2000 Aug 1;14(15):1837-51
10921899
Genes Chromosomes Cancer. 2002 Jul;34(3):285-98
12007189
Melanoma Res. 2001 Oct;11(5):451-9
11595881
Exp Cell Res. 2000 Apr 10;256(1):192-202
10739666
J Immunol. 2004 Mar 1;172(5):3289-96
14978137
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11810-3
8524854
J Exp Med. 1965 Sep 1;122(3):467-81
4953873
Nature. 1994 Jul 21;370(6486):213-6
8028667
Cancer Immun. 2004 Jan 23;4:1
14738373
J Biol Chem. 2004 Jan 16;279(3):1703-12
14593116
Placenta. 2001 May;22(5):490-8
11373160
Gene. 1999 Oct 1;238(2):301-13
10570958
Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):101-12
14734458
Mol Cells. 2002 Apr 30;13(2):288-95
12018852
Science. 1947 Mar 14;105(2724):287-9
17835147
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5211-6
9560255
Biochem Soc Trans. 1997 May;25(2):544-8
9191153
Mol Cell Biol. 1999 Nov;19(11):7327-35
10523621
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8709-14
9671743
Int J Cancer. 2004 Jan 10;108(2):307-13
14639620